webinar register page

Webinar banner
Gene editing to treat hyperlipidemia and to prevent coronary heart disease
People naturally born with beneficial DNA variants that turn off cholesterol and triglyceride genes like PCSK9 and ANGPTL3 enjoy substantially lower lifetime risk of coronary heart disease, without any serious adverse consequences. Gene editing makes it possible to introduce similar beneficial DNA variants in adult patients--a potential one-shot therapy to permanently reduce cholesterol or triglyceride levels and confer lifelong protection against coronary heart disease.

Aug 4, 2020 06:00 PM in Eastern Time (US and Canada)

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Marlo Polonsky.